[3P-0661] MHC Class I presentation by highly functional epitope peptides of M. tuberculosis shared among the antigen 85 complex

〇Shihoko Komine-Aizawa¹, Satoshi Hayakawa¹, Kazuhiro Matsuo², Mitsuo Honda¹ (1.Division of Microbiology, Department of Pathology and Microbiology, Nihon Univ. of School of Medicine, 2.Japan BCG Laboratory)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0662] Impact of IFN-lambda2 on the rubella virus infection

〇Daiki Kambayashi^1,2, Takako Kurata¹, Takahiro Yumisashi¹, Jun Komano³ (1.Dept. of Infectious Diseases, Osaka Prefectural Institute of Public health, 2.Dept. of Microbiology, Osaka City Institute of Public Health and Environmental Sciences, 3.Dept. of Clinical Laboratory, Nagoya Medical Center)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0663] Accumulation of nucleoporins to noroviral replication complex

〇Akira Nakanishi¹, Kazuhiko Katayama², Reiko Todaka², Kumiko Kanamori¹, Kei Haga², Akira Fujimoto², Akiko Kato¹, Kazuhiro Yoshida¹ (1.National Center for Geriatrics and Gerontology, 2.National Institute for Infectious Diseases)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0664] Valosin-containing protein is required during the West Nile virus life cycle

〇Wallaya Phongphaew¹, Shintaro Kobayashi^1,2, Michihito Sasaki¹, Yasuko Orba¹, Hirofumi Sawa^1,3 (1.Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, 2.Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, 3.Global Institution for Collaborative Research and Education (GI-CoRE), Global Station for Zoonosis Control, Hokkaido University)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0665] Evaluation of anti-HBV effect of a novel candidate compound for hepatitis B therapeutics

〇Aya Yamashita¹, Hiroki Okumura², Tadahiro Hashita^1,2, Yasuhito Tanaka³, Tamihide Matsunaga^1,2 (1.Dep. of Cli. Pha., Fac. Sch. of Pha. Sci., Nagoya City Univ., 2.Dep. of Cli. Pha., Gra. Sch. of Pha. Sci., Nagoya City Univ., 3.Dep. of Pathol. Med. Sci., Gra. Sch. of Med. Sci., Nagoya City Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0666] Association of HLA genes with hepatitis B infection in the Japanese population

〇Nao Nishida^1,2, Hiromi Sawai², Jun Ohashi³, Seik-Soon Khor², Masaya Sugiyama¹, Takayo Tsuchiura¹, Mayumi Ishii¹, Katsushi Tokunaga², Masashi Mizokami^1,2 (1.Genome Med. Sci. Proj., NCGM, 2.Dept. of Hum. Genet., Grad. Sch. of Med., Univ. of Tokyo, 3.Dept. of Biol. Sci., Grad. Sch. of Sci., Univ. of Tokyo)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0667] The functional mechanism of therapeutic vaccine against hepatitis C virus

〇Takahiro Ohtsuki¹, Yuko Tokunaga¹, Michinori Kohara¹ (1.Tokyo metropolitan Institute of medical science)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0668] Interaction of HBV HBx with MDFI results in the repression of MDFI-mediated transcriptional regulation

〇Shuichi Kusano¹, Masanori Ikeda¹ (1.Div. of Persistent&Oncogenic Viruses, Cent. for Chronic Viral Diseases, Kagoshima Univ.)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0669] Clofarabine exhibits multifunctional antiviral activity for hepatoma virus

〇Midori Takeda¹, Hiromichi Dansako², Masanori Baba³, Nobuyuki Kato², Masanori Ikeda¹ (1.Div. of Persistent and Oncogenic Viruses, Ctr. for Chronic Viral Diseases, Grad. Sch. of Med. and Dent. Sci., Univ. of Kagoshima, 2.Dept. of Tumor Virology, Grad. Sch. of Med. Dent. and Pharm. Sci., Univ. of Okayama, 3.Div. of Antiviral Chemotherapy, Ctr. for Chronic Viral Diseases, Grad. Sch. of Med. and Dent. Sci., Univ. of Kagoshima)

The 39th Annual Meeting of the Molecular Biology Society of Japan

[3P-0670] Identification and functional analysis of novel E3 ligases interacting with HCV NS4B.

〇Mei Imamura¹, Hirotaka Takahashi¹, Hiroyuki Takeda¹, Masahiko Ito², Tetsuro Suzuki², Takaji Wakita³, Tatsuya Sawasaki¹ (1.Proteo-Science Center, Ehime University, 2.Department of Infectious Diseases, Hamamatsu University School of Medicine, 3.Department of Virology II, National Institute of Infectious Diseases)

The 39th Annual Meeting of the Molecular Biology Society of Japan